Study of Optimal Treatment Plan in Hypertensives With Anti-AT1-Receptor Autoantibody
Clinical trial NCT00360763 · UNKNOWN
Trial details
- NCT number
- NCT00360763
- Sponsor
- Huazhong University of Science and Technology
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.